• Further plans for Stevenage campus expansion shared
• Developer partners announced as Reef Group and UBS Asset Management
• GSK to gift land to SBC to enable expansion
STEVENAGE 4th July: Stevenage Bioscience Catalyst (SBC) is based on the life science campus in Stevenage, Hertfordshire. Details of plans to expand the campus were shared today.
05 July 2022
Cambridge, UK, Tokyo, Japan, 05 July 2022: Mogrify Limited (CEO: Darrin M. Disley, Ph.D., “Mogrify®”), a biopharmaceutical company transforming the lives of patients through a novel class of in vivo reprogramming therapies, and Astellas Pharma Inc. (TSE: 4503, President and CEO: Kenji Yasukawa, Ph.D., “Astellas”), a leader in regenerative medicine, today announced that they have executed a collaborative research agreement on in vivo regenerative medicine approaches to address sensorineural hearing loss.
Cambridge, UK, 4 July 2022: Arecor Therapeutics plc (AIM: AREC), a globally focused biopharmaceutical company advancing today’s therapies to enable healthier lives, today announces that its abstract titled “Phase I study investigating PK and PD of highly-concentrated insulin aspart AT278 U500” has been selected for presentation as part of the Short Oral Discussion Session A at the 58th Annual Meeting of the European Association for the Study of Diabetes (EASD) meeting, which will be held from 19-23 September 2022 in Stockholm, Sweden and online.
Jun 28, 2022
Investment from LifeArc, Illumina, and Illumina Ventures will fund genomics startups for Illumina Accelerator Cambridge graduates
Cambridge: 24 June 2022
One Nucleus is pleased to announce an exciting collaboration with My Green Lab to support its member organisations in becoming more sustainable. We will be sign-posting the ‘My Green Lab Certification’ complimentary program and providing a discount, exclusive to One Nucleus Members, for the Accredited Professional training courses.
Cambridge’s new urban innovation district welcomes Royal party and guests to celebrate its existing innovative community and mark the next stage of campus development
Cambridge, 28th June 2022: HRH The Duke of Gloucester visited the new Unity Campus development in Cambridge on Friday 24th June.
The development will provide much needed accommodation to the burgeoning life science community within the Cambridge Cluster
Andy Billinton PhD appointed as Chief Scientific Officer
Expansion into larger facilities at the Babraham Research Campus
Cambridge, 23rd June 2022: Transine Therapeutics today announced the appointment of Andy Billinton as Chief Scientific Officer as it triples its facility footprint at The Babraham Research Campus.
A Charnwood Campus Cluster event, part of a series of events to support the growth and success of the life science organisations clustered around Charnwood Campus Science, Innovation and Technology Park
Scorching temperatures, sizzling burgers and great company awaited members of the Norwich Research Park community who joined Anglia Innovation Partnership LLP (AIP) at their community summer barbecue sponsored by Chadwicks and Fortus.
The event was held on the grass and terrace area just outside the Centrum building attended by over 200 guests, from businesses and park partner organisations, who joined in the fun with networking, games and great food from the Genuine Dining Company.